The global insulin delivery devices market, worth $9,499.1 million in 2014, is expected to grow at a CAGR of 7.0% during 2015-2020. The insulin syringes segment held the largest share of 33% in the global insulin delivery devices market; whereas, the insulin pump was the fastest growing segment in the same year. The insulin pump market is escalating with high growth rate due to several factors such as technological advancements in insulin pumps to maintain the level of insulin in the body, increasing awareness of diabetes, and increasing prevalence of diabetes. Rising awareness of diabetes have been imparting positive impact on insulin delivery devices market, as people are increasingly adopting new technology to maintain insulin level in body and experience better results from the delivery devices.
Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors. The insulin syringes are most commonly used delivery systems for self-medication. However, for some people insulin syringe is not convenient option, which resulted in development of other devices for the treatment of diabetes. Insulin pens and pumps have various advantages, which help in delivering accurate dosage of insulin and maintain the normal level of insulin in body. Usage of insulin pen in administering insulin is less time-consuming compared to the usage of syringes and vials.
View Full Report with TOC at:
The increasing awareness of diabetes across the globe through campaigns, conferences and activities is creating awareness about the long term effects and complications of diabetes, encouraging people to enter regular diabetes checkups. Moreover, obesity is caused due to diet imbalance, leading to various risk factors for Type 2 diabetes, high blood pressure, heart disease and other health problems. Risk factors of Type 2 diabetes and high blood pressure are increasing steadily with rise in prevalence of obesity, which is consequently driving the growth of the insulin delivery device market.
The prevalence of diabetes is also increasing every year. It is one of the leading causes of death and has increased risk of developing number of serious health problems. It is the major cause of cardiovascular disease, kidney disease, eye disorders and stroke. Also, increase in geriatric population is also driving the growth of the global insulin delivery device market.
The restraints associated with insulin delivery devices market include high insulin analogue cost and hazards and risks associated with the drug delivery devices. The insulin pen needle is for single use, although many diabetic patients re-use needle for delivery of insulin. The re-use of needle could lead to bacterial growth on the needle, risk of lipohypertrophy and risk of breaking fine tip of needle. Similarly, the risk associated with jet injectors are accuracy of insulin dosage and improper injection. Improper injection of insulin can lead to altered absorption level of insulin in the blood stream and bruising. However, limited number of insulin producers and high price variation in different countries impedes the growth of the market.
The key companies operating in the global insulin delivery device market include Medtronic, Inc., F. Hoffmann-La Roche, Ltd., Abbott Laboratories Inc. Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Becton Dickinson and Company, Insulet Corporation, B. Braun Melsungen AG, Animas Corporation, and Ypsomed Holdings AG.
Browse All Reports of This Category at:
Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
Uncovers potential demands in the market
Porter analysis identifies competitive forces within the market
Provides information on the historical and current market size and the future potential of the market
Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)
Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger acquisitions
Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics.
Profiles provide better understanding of competition as well as the demands of the market
Scope of Report
This research offers actual historical market size (2011 – 2014) and forecast market size (2015 – 2020) of the global insulin delivery devices market in the U.S. dollars.
GLOBAL INSULIN DELIVERY DEVICES MARKET
By Type – Insulin Syringes, Insulin Pumps, Insulin Pen, Insulin Jet Injectors and Others
By Region – North America, Europe, Asia and Rest of World
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY TYPE
Insulin syringes market breakdown by region
Insulin pump market breakdown by region
Insulin pen market breakdown by region
Insulin jet injectors market breakdown by region
Others market breakdown by region
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY GEOGRAPHY
North America Insulin Delivery Devices Market
North America insulin delivery devices market breakdown by country – The U.S., Canada, and Rest of North America
The U.S. insulin delivery devices market
Canada insulin delivery devices market
Europe Insulin Delivery Device Market
Europe insulin delivery devices market breakdown by country – Germany, the U.K., France, Italy, Spain, and Rest of Europe
Germany insulin delivery devices market
The U.K. insulin delivery devices market
France insulin delivery devices market
Italy insulin delivery devices market
Spain insulin delivery devices market
Asia Insulin Delivery Devices Market
Asia-Pacific insulin delivery devices market breakdown by country – China, Japan, India and Rest of Asia
China insulin delivery devices market
Japan insulin delivery devices market
India insulin delivery devices market
Rest of the World Insulin Delivery Devices Market
Rest of the World (RoW) insulin delivery devices market breakdown
About Acute Market Reports
Acute Market Reports is the most sufficient collection of market intelligence services online. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.
For More Information, Visit Acute Market Report
Company Name: Acute Market Reports
Contact Person: Chris Paul
Address:Office No 01, 1st Floor, Aditi Mall, Baner